These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9408915)

  • 21. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.
    Vollenweider FX; Vontobel P; Hell D; Leenders KL
    Neuropsychopharmacology; 1999 May; 20(5):424-33. PubMed ID: 10192823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography.
    Dewey SL; Smith GS; Logan J; Brodie JD; Yu DW; Ferrieri RA; King PT; MacGregor RR; Martin TP; Wolf AP
    J Neurosci; 1992 Oct; 12(10):3773-80. PubMed ID: 1357114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects.
    Verhoeff NP; Kapur S; Hussey D; Lee M; Christensen B; C Psych ; Papatheodorou G; Zipursky RB
    Neuropsychopharmacology; 2001 Aug; 25(2):213-23. PubMed ID: 11425505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for striatal dopamine release during a video game.
    Koepp MJ; Gunn RN; Lawrence AD; Cunningham VJ; Dagher A; Jones T; Brooks DJ; Bench CJ; Grasby PM
    Nature; 1998 May; 393(6682):266-8. PubMed ID: 9607763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in psychiatric brain imaging.
    Sedvall G; Farde L; Nybäck H; Pauli S; Persson A; Savic I; Wiesel FA
    Acta Radiol Suppl; 1990; 374():113-5. PubMed ID: 1966956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine.
    Schiffer WK; Logan J; Dewey SL
    Neuropsychopharmacology; 2003 Dec; 28(12):2192-8. PubMed ID: 12888780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.
    Mawlawi O; Martinez D; Slifstein M; Broft A; Chatterjee R; Hwang DR; Huang Y; Simpson N; Ngo K; Van Heertum R; Laruelle M
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1034-57. PubMed ID: 11524609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Schlyer D; Hitzemann R; Lieberman J; Angrist B; Pappas N; MacGregor R
    Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers.
    Adler CM; Elman I; Weisenfeld N; Kestler L; Pickar D; Breier A
    Neuropsychopharmacology; 2000 May; 22(5):545-50. PubMed ID: 10731630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
    Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence.
    Hietala J; West C; Syvälahti E; Någren K; Lehikoinen P; Sonninen P; Ruotsalainen U
    Psychopharmacology (Berl); 1994 Nov; 116(3):285-90. PubMed ID: 7892418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.
    Schlaepfer TE; Pearlson GD; Wong DF; Marenco S; Dannals RF
    Am J Psychiatry; 1997 Sep; 154(9):1209-13. PubMed ID: 9286178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
    Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
    Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.
    Soliman A; O'Driscoll GA; Pruessner J; Holahan AL; Boileau I; Gagnon D; Dagher A
    Neuropsychopharmacology; 2008 Jul; 33(8):2033-41. PubMed ID: 17957215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.
    Wang GJ; Volkow ND; Fowler JS; Logan J; Pappas NR; Wong CT; Hitzemann RJ; Netusil N
    J Nucl Med; 1999 Aug; 40(8):1285-91. PubMed ID: 10450679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.
    Onoe H; Inoue O; Suzuki K; Tsukada H; Itoh T; Mataga N; Watanabe Y
    Brain Res; 1994 Nov; 663(2):191-8. PubMed ID: 7874501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography.
    Neu H; Hartvig P; Torstenson R; Fasth KJ; Sonesson C; Waters N; Carlsson A; Tedroff J; Långström B
    Nucl Med Biol; 1997 Aug; 24(6):507-11. PubMed ID: 9316077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
    DeLorenzo C; DellaGioia N; Bloch M; Sanacora G; Nabulsi N; Abdallah C; Yang J; Wen R; Mann JJ; Krystal JH; Parsey RV; Carson RE; Esterlis I
    Biol Psychiatry; 2015 Feb; 77(3):266-275. PubMed ID: 25156701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of dopamine D
    Hashimoto K; Kakiuchi T; Ohba H; Nishiyama S; Tsukada H
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):173-176. PubMed ID: 27091456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain.
    Volkow ND; Fowler JS; Wang GJ; Dewey SL; Schlyer D; MacGregor R; Logan J; Alexoff D; Shea C; Hitzemann R
    J Nucl Med; 1993 Apr; 34(4):609-13. PubMed ID: 8455077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.